Literature DB >> 17073438

Importance of Ca(2+)-dependent transamidation activity in the protection afforded by tissue transglutaminase against doxorubicin-induced apoptosis.

Sunando Datta1, Marc A Antonyak, Richard A Cerione.   

Abstract

Tissue transglutaminase II (TGase-II), which is capable of both GTP binding and transamidation activities, has been implicated in a variety of biological disorders ranging from cancer to neurodegenerative diseases. Recent studies have suggested that the transamidation activity of TGase-II is necessary for the survival of cancer cells confronted with different stresses and cellular insults. When assayed in vitro, the transamidation activity of TGase-II is Ca(2+)-dependent. However, at present, little is known with regard to how the regulation by Ca(2+) is manifested or if in fact it is important for the cellular functions of TGase-II. Here, we have set out to further examine the Ca(2+)-mediated regulation of TGase-II's transamidation activity, with our goals being to identify the Ca(2+)-regulatory sites on the protein and determine whether they are essential for TGase-II to confer survival to human breast cancer cells. On the basis of comparisons between the X-ray crystal structures of TGase-II and TGase-III, we identified three putative Ca(2+)-regulatory sites on TGase-II. Site-directed mutagenesis was performed to individually alter key residues at each of the sites. These substitutions did not affect the ability of TGase-II to bind guanine nucleotides, nor did they cause any obvious changes in its cellular localization. While substitutions at the different Ca(2+)-regulatory sites could either slightly enhance or markedly reduce the GTP hydrolytic activity of TGase-II, mutations at each of the three sites inhibited the Ca(2+)-responsive transamidation activity. We further showed that the same substitutions inhibited the ability of TGase-II to protect human breast cancer cells against the apoptotic activity of doxorubicin. Overall, these findings demonstrate that the Ca(2+)-mediated regulation of transamidation activity is essential for the ability of TGase-II to confer cell survival.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17073438      PMCID: PMC2596610          DOI: 10.1021/bi0606795

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  43 in total

1.  Fluorescent BODIPY-GTP analogs: real-time measurement of nucleotide binding to G proteins.

Authors:  D P McEwen; K R Gee; H C Kang; R R Neubig
Journal:  Anal Biochem       Date:  2001-04-01       Impact factor: 3.365

2.  Effects of tissue transglutaminase on retinoic acid-induced cellular differentiation and protection against apoptosis.

Authors:  M A Antonyak; U S Singh; D A Lee; J E Boehm; C Combs; M M Zgola; R L Page; R A Cerione
Journal:  J Biol Chem       Date:  2001-07-03       Impact factor: 5.157

Review 3.  Tissue transglutaminase: a possible role in neurodegenerative diseases.

Authors:  M Lesort; J Tucholski; M L Miller; G V Johnson
Journal:  Prog Neurobiol       Date:  2000-08       Impact factor: 11.685

4.  Three-dimensional structure of the human transglutaminase 3 enzyme: binding of calcium ions changes structure for activation.

Authors:  Bijan Ahvazi; Hee Chul Kim; Sun-Ho Kee; Zoltan Nemes; Peter M Steinert
Journal:  EMBO J       Date:  2002-05-01       Impact factor: 11.598

5.  Analysis of tissue transglutaminase function in the migration of Swiss 3T3 fibroblasts: the active-state conformation of the enzyme does not affect cell motility but is important for its secretion.

Authors:  Zita Balklava; Elisabetta Verderio; Russell Collighan; Stephane Gross; Julian Adams; Martin Griffin
Journal:  J Biol Chem       Date:  2002-02-26       Impact factor: 5.157

6.  Structural basis for the guanine nucleotide-binding activity of tissue transglutaminase and its regulation of transamidation activity.

Authors:  Shenping Liu; Richard A Cerione; Jon Clardy
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

7.  Tissue transglutaminase protects against apoptosis by modifying the tumor suppressor protein p110 Rb.

Authors:  Jason E Boehm; Ugra Singh; Carolyn Combs; Marc A Antonyak; Richard A Cerione
Journal:  J Biol Chem       Date:  2002-04-15       Impact factor: 5.157

8.  Tissue transglutaminase serves as an inhibitor of apoptosis by cross-linking caspase 3 in thapsigargin-treated cells.

Authors:  Hirohito Yamaguchi; Hong-Gang Wang
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

9.  Identification of a guanosine triphosphate-binding site on guinea pig liver transglutaminase. Role of GTP and calcium ions in modulating activity.

Authors:  K E Achyuthan; C S Greenberg
Journal:  J Biol Chem       Date:  1987-02-05       Impact factor: 5.157

10.  Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin.

Authors:  S S Akimov; D Krylov; L F Fleischman; A M Belkin
Journal:  J Cell Biol       Date:  2000-02-21       Impact factor: 10.539

View more
  21 in total

Review 1.  Transglutaminase 2: a molecular Swiss army knife.

Authors:  Soner Gundemir; Gozde Colak; Janusz Tucholski; Gail V W Johnson
Journal:  Biochim Biophys Acta       Date:  2011-10-10

2.  Identification of chemical inhibitors to human tissue transglutaminase by screening existing drug libraries.

Authors:  Thung-S Lai; Yusha Liu; Tim Tucker; Kurt R Daniel; David C Sane; Eric Toone; James R Burke; Warren J Strittmatter; Charles S Greenberg
Journal:  Chem Biol       Date:  2008-09-22

3.  Doxorubicin induces the persistent activation of intracellular transglutaminase 2 that protects from cell death.

Authors:  Sung-Yup Cho; Eui Man Jeong; Jin-Haeng Lee; Hyo-Jun Kim; Jisun Lim; Chai-Wan Kim; Dong-Myung Shin; Ju-Hong Jeon; Kyungho Choi; In-Gyu Kim
Journal:  Mol Cells       Date:  2012-02-28       Impact factor: 5.034

4.  Structural characterization of a conserved, calcium-dependent periplasmic protease from Legionella pneumophila.

Authors:  Debashree Chatterjee; Chelsea D Boyd; George A O'Toole; Holger Sondermann
Journal:  J Bacteriol       Date:  2012-06-15       Impact factor: 3.490

5.  The Different Conformational States of Tissue Transglutaminase Have Opposing Affects on Cell Viability.

Authors:  Garima Singh; Jingwen Zhang; Yilun Ma; Richard A Cerione; Marc A Antonyak
Journal:  J Biol Chem       Date:  2016-02-18       Impact factor: 5.157

6.  Transglutaminase-1 protects renal epithelial cells from hydrogen peroxide-induced apoptosis through activation of STAT3 and AKT signaling pathways.

Authors:  Murugavel Ponnusamy; Maoyin Pang; Pavan Kumar Annamaraju; Zhu Zhang; Rujun Gong; Y Eugene Chin; Shougang Zhuang
Journal:  Am J Physiol Renal Physiol       Date:  2009-08-26

7.  A mechanism for the upregulation of EGF receptor levels in glioblastomas.

Authors:  Jingwen Zhang; Marc A Antonyak; Garima Singh; Richard A Cerione
Journal:  Cell Rep       Date:  2013-06-13       Impact factor: 9.423

Review 8.  Transglutaminases and neurodegeneration.

Authors:  Thomas M Jeitner; John T Pinto; Boris F Krasnikov; Mark Horswill; Arthur J L Cooper
Journal:  J Neurochem       Date:  2009-05       Impact factor: 5.372

9.  Transglutaminase 2 regulates the GTPase-activating activity of Bcr.

Authors:  Sun-Ju Yi; John Groffen; Nora Heisterkamp
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

10.  The mechanism of transglutaminase 2 inhibition with glucosamine: implications of a possible anti-inflammatory effect through transglutaminase inhibition.

Authors:  Kyung-Chae Jeong; Kyung-Ohk Ahn; Byung Il Lee; Chang-Hoon Lee; Soo-Youl Kim
Journal:  J Cancer Res Clin Oncol       Date:  2010-01       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.